NCT03591926 - A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF) | Biotech Hunter

Timeline

Start Date

January 31, 1900

Primary Completion Date

January 31, 1900

Study Completion Date

January 31, 1900

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

SM04646

"Nebulized, inhaled solution; single dose concentration dosed once per day for 12 weeks; dosing pattern will follow a 2 weeks on, 2 weeks off regimen, wherein subjects will dose 5 consecutive days of each 7 day on week."

Trial Locations (6)

Unknown

Research Site, Camperdown

Research Site, Concord

Research Site, Bedford Park

Research Site, Clayton

Research Site, Christchurch

Research Site, Dunedin